VRDN
$17.07
Viridian Therapeutics
$.50
3.02%
VRDN
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($1.19)
Revenue:  $0.00 Mil
Wednesday
Nov 10
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when VRDN reports earnings?
Beat
Meet
Miss

Where is VRDN's stock price going from here?
Up
Flat
Down
Stock chart of VRDN
Analysts
Summary of analysts' recommendations for VRDN
Score
Grade
Pivots
Resistance
$18.43
$17.80
$17.43

$16.80

Support
$16.44
$15.81
$15.44
Tweet
Growth
Description
Viridian Therapeutics Inc. is a biotechnology company advancing new treatments for patients suffering from serious diseases. The company's program includes VRDN-001, which is in clinical stage. Viridian Therapeutics Inc., formerly known as miRagen Therapeutics Inc., is based in BOULDER, Colo.